Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
93 participants
OBSERVATIONAL
2010-03-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective is to evaluate the safety profile of Macrolane Volume Restoration Factor 20 and Macrolane Volume Restoration Factor 30 when used for female breast enhancement in clinical practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Macrolane Prospective Survey
NCT01223066
Macrolane VRF30 for Enhancement of Shape and Fullness of Female Breast
NCT01299532
Macrolane for Enhancement of the Shape and Fullness of the Female Breast
NCT01308853
Treatment of Pectus Excavatum Deformity Using Macrolane Filler
NCT01750112
A Study to Evaluate Efficacy and Safety of Macrolane VRF30 for Volume Restoration and Contouring of the Buttocks
NCT01331408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Macrolane
Women that have had breast enhancement with Macrolane Volume Restoration Factor.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed Informed Consent
Exclusion Criteria
* Subjects that have participated or participates in clinical studies with Macrolane for breast enhancement
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per Hedén, Md PhD
Role: PRINCIPAL_INVESTIGATOR
Akademikliniken
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stureplanskliniken
Gothenburg, , Sweden
Akademikliniken
Malmo, , Sweden
Stureplanskliniken
Stockholm, , Sweden
Akademikliniken
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31GB0902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.